Supplemental material
Leukemia & Lymphoma
Volume 59, 2018 - Issue 3
Original Articles: Research
The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma
Katalin Piroska KissLaboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary; 
http://orcid.org/0000-0001-8265-219XView further author information
http://orcid.org/0000-0001-8265-219XView further author information, Gergely Varga3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary; http://orcid.org/0000-0001-6875-056XView further author information
http://orcid.org/0000-0001-6875-056XView further author information, Gabor MikalaDepartment of Haematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest, Hungary; http://orcid.org/0000-0003-2204-7398View further author information
http://orcid.org/0000-0003-2204-7398View further author information, Katalin BalassaLaboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary; http://orcid.org/0000-0002-5911-2440View further author information
http://orcid.org/0000-0002-5911-2440View further author information, Andras BorsLaboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary; http://orcid.org/0000-0003-2109-4678View further author information
http://orcid.org/0000-0003-2109-4678View further author information, , , , , , , Attila TordaiDepartment of Pathophysiology, Semmelweis University, Budapest, Hungaryhttp://orcid.org/0000-0001-6966-1622View further author information
http://orcid.org/0000-0001-6966-1622View further author information, Tamas Masszi3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary; ;Department of Haematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest, Hungary; http://orcid.org/0000-0002-9038-302XView further author information
http://orcid.org/0000-0002-9038-302XView further author information & Hajnalka AndrikovicsLaboratory of Molecular Diagnostics, Hungarian National Blood Transfusion Service, Budapest, Hungary; Correspondence[email protected]
http://orcid.org/0000-0002-8368-9784View further author information
http://orcid.org/0000-0002-8368-9784View further author information show all